Neurogene Inc. (NASDAQ:NGNE) Receives Average Rating of “Buy” from Analysts
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […]
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […]
